Listed

Relmada Therapeutics, Inc.

RLMDNasdaqCIK 1553643HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$15.0m, Q2 FY2026
Net income−$12.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m10.5Research and development, Q3 FY2023, three months to 2023-09-30$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure14.8Research and development, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001013762-25-003426. Derived: 12-month figure less the 9-month figure.Report this figure13.3Research and development, Q1 FY2024, three months to 2024-03-31$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure10.7Research and development, Q2 FY2024, three months to 2024-06-30$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure11.1Research and development, Q3 FY2024, three months to 2024-09-30$11.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure11.0Research and development, Q4 FY2024, three months to 2024-12-31$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure12.0Research and development, Q1 FY2025, three months to 2025-03-31$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure2.8Research and development, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure4.0Research and development, Q3 FY2025, three months to 2025-09-30$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure8.1Research and development, Q4 FY2025, three months to 2025-12-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure8.1Research and development, Q1 FY2026, three months to 2026-03-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure8.4Research and development, Q2 FY2026, three months to 2026-06-30$8.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Operating income$m(22.7)Operating income, Q3 FY2023, three months to 2023-09-30−$22.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure(26.8)Operating income, Q4 FY2023, three months to 2023-12-31−$26.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001013762-25-003426. Derived: 12-month figure less the 9-month figure.Report this figure(23.0)Operating income, Q1 FY2024, three months to 2024-03-31−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure(18.8)Operating income, Q2 FY2024, three months to 2024-06-30−$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure(23.0)Operating income, Q3 FY2024, three months to 2024-09-30−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure(19.1)Operating income, Q4 FY2024, three months to 2024-12-31−$19.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure(18.2)Operating income, Q1 FY2025, three months to 2025-03-31−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(10.2)Operating income, Q2 FY2025, three months to 2025-06-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure(10.3)Operating income, Q3 FY2025, three months to 2025-09-30−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure(20.3)Operating income, Q4 FY2025, three months to 2025-12-31−$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure(19.5)Operating income, Q1 FY2026, three months to 2026-03-31−$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(15.0)Operating income, Q2 FY2026, three months to 2026-06-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(22.0)Net income, Q3 FY2023, three months to 2023-09-30−$22.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure(25.2)Net income, Q4 FY2023, three months to 2023-12-31−$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001013762-25-003426. Derived: 12-month figure less the 9-month figure.Report this figure(21.8)Net income, Q1 FY2024, three months to 2024-03-31−$21.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure(17.8)Net income, Q2 FY2024, three months to 2024-06-30−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure(21.7)Net income, Q3 FY2024, three months to 2024-09-30−$21.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure(18.7)Net income, Q4 FY2024, three months to 2024-12-31−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Net income, Q1 FY2025, three months to 2025-03-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure(9.9)Net income, Q2 FY2025, three months to 2025-06-30−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure(10.1)Net income, Q3 FY2025, three months to 2025-09-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure(19.9)Net income, Q4 FY2025, three months to 2025-12-31−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure(19.1)Net income, Q1 FY2026, three months to 2026-03-31−$19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure(12.9)Net income, Q2 FY2026, three months to 2026-06-30−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Diluted EPS$ per share(0.73)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figurenot reported(0.72)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure(0.59)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure(0.72)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figurenot reported(0.58)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(0.30)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure(0.30)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figurenot reported(0.22)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(0.11)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Basic EPS$ per share(0.73)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figurenot reported(0.72)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure(0.59)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure(0.72)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figurenot reported(0.58)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(0.30)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure(0.30)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figurenot reported(0.22)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(0.11)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure

Balance sheet

Cash and equivalents$11.3m, Q2 FY2026
Shareholders' equity$206.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m6.7Cash and equivalents, Q3 FY2023, at 2023-09-30$6.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001213900-23-084737.Report this figure4.1Cash and equivalents, FY2023, at 2023-12-31$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001013762-25-003426.Report this figure1.3Cash and equivalents, Q1 FY2024, at 2024-03-31$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001213900-24-040856.Report this figure2.1Cash and equivalents, Q2 FY2024, at 2024-06-30$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001213900-24-066111.Report this figure1.5Cash and equivalents, Q3 FY2024, at 2024-09-30$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure3.9Cash and equivalents, FY2024, at 2024-12-31$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001213900-26-031862.Report this figure1.1Cash and equivalents, Q1 FY2025, at 2025-03-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure1.4Cash and equivalents, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure1.4Cash and equivalents, Q3 FY2025, at 2025-09-30$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure3.5Cash and equivalents, FY2025, at 2025-12-31$3.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure9.8Cash and equivalents, Q1 FY2026, at 2026-03-31$9.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure11.3Cash and equivalents, Q2 FY2026, at 2026-06-30$11.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Current assets$m109Current assets, Q3 FY2023, at 2023-09-30$109.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001213900-23-084737.Report this figure97.5Current assets, FY2023, at 2023-12-31$97.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001013762-25-003426.Report this figure84.4Current assets, Q1 FY2024, at 2024-03-31$84.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001213900-24-040856.Report this figure71.0Current assets, Q2 FY2024, at 2024-06-30$71.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001213900-24-066111.Report this figure55.7Current assets, Q3 FY2024, at 2024-09-30$55.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure45.8Current assets, FY2024, at 2024-12-31$45.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001213900-26-031862.Report this figure27.7Current assets, Q1 FY2025, at 2025-03-31$27.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure21.1Current assets, Q2 FY2025, at 2025-06-30$21.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure14.9Current assets, Q3 FY2025, at 2025-09-30$14.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure94.0Current assets, FY2025, at 2025-12-31$94.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure235Current assets, Q1 FY2026, at 2026-03-31$235.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure219Current assets, Q2 FY2026, at 2026-06-30$219.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Total assets$m109Total assets, Q3 FY2023, at 2023-09-30$109.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001213900-23-084737.Report this figure97.6Total assets, FY2023, at 2023-12-31$97.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001013762-25-003426.Report this figure84.4Total assets, Q1 FY2024, at 2024-03-31$84.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001213900-24-040856.Report this figure71.0Total assets, Q2 FY2024, at 2024-06-30$71.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001213900-24-066111.Report this figure55.7Total assets, Q3 FY2024, at 2024-09-30$55.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure45.8Total assets, FY2024, at 2024-12-31$45.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001213900-26-031862.Report this figure27.7Total assets, Q1 FY2025, at 2025-03-31$27.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure21.1Total assets, Q2 FY2025, at 2025-06-30$21.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure14.9Total assets, Q3 FY2025, at 2025-09-30$14.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure94.0Total assets, FY2025, at 2025-12-31$94.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure235Total assets, Q1 FY2026, at 2026-03-31$235.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure219Total assets, Q2 FY2026, at 2026-06-30$219.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Current liabilities$m8.4Current liabilities, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001213900-23-084737.Report this figure12.2Current liabilities, FY2023, at 2023-12-31$12.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001013762-25-003426.Report this figure12.4Current liabilities, Q1 FY2024, at 2024-03-31$12.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001213900-24-040856.Report this figure9.5Current liabilities, Q2 FY2024, at 2024-06-30$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001213900-24-066111.Report this figure8.1Current liabilities, Q3 FY2024, at 2024-09-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure10.3Current liabilities, FY2024, at 2024-12-31$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001213900-26-031862.Report this figure5.2Current liabilities, Q1 FY2025, at 2025-03-31$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure5.1Current liabilities, Q2 FY2025, at 2025-06-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure5.2Current liabilities, Q3 FY2025, at 2025-09-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure6.4Current liabilities, FY2025, at 2025-12-31$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure12.9Current liabilities, Q1 FY2026, at 2026-03-31$12.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure7.4Current liabilities, Q2 FY2026, at 2026-06-30$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Total liabilities$mnot reported12.2Total liabilities, FY2023, at 2023-12-31$12.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001013762-25-003426.Report this figure12.4Total liabilities, Q1 FY2024, at 2024-03-31$12.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001213900-24-040856.Report this figurenot reported8.1Total liabilities, Q3 FY2024, at 2024-09-30$8.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure10.3Total liabilities, FY2024, at 2024-12-31$10.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001213900-26-031862.Report this figure5.2Total liabilities, Q1 FY2025, at 2025-03-31$5.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure5.2Total liabilities, Q2 FY2025, at 2025-06-30$5.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure5.4Total liabilities, Q3 FY2025, at 2025-09-30$5.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure7.5Total liabilities, FY2025, at 2025-12-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure16.6Total liabilities, Q1 FY2026, at 2026-03-31$16.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure12.5Total liabilities, Q2 FY2026, at 2026-06-30$12.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure
Shareholders' equity$m101Shareholders' equity, Q3 FY2023, at 2023-09-30$100.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure85.4Shareholders' equity, FY2023, at 2023-12-31$85.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001213900-26-031862.Report this figure72.0Shareholders' equity, Q1 FY2024, at 2024-03-31$72.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure61.5Shareholders' equity, Q2 FY2024, at 2024-06-30$61.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure47.6Shareholders' equity, Q3 FY2024, at 2024-09-30$47.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure35.5Shareholders' equity, FY2024, at 2024-12-31$35.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure22.4Shareholders' equity, Q1 FY2025, at 2025-03-31$22.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure15.9Shareholders' equity, Q2 FY2025, at 2025-06-30$15.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure9.5Shareholders' equity, Q3 FY2025, at 2025-09-30$9.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure86.5Shareholders' equity, FY2025, at 2025-12-31$86.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure219Shareholders' equity, Q1 FY2026, at 2026-03-31$218.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure207Shareholders' equity, Q2 FY2026, at 2026-06-30$206.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure

Cash flow

Operating cash flow−$9.6m, Q2 FY2026
Share repurchases$6.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(11.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001213900-24-095398. Derived: 9-month figure less the 6-month figure.Report this figure(10.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001013762-25-003426. Derived: 12-month figure less the 9-month figure.Report this figure(13.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure(13.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001213900-25-073073. Derived: 6-month figure less the 3-month figure.Report this figure(16.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-109983. Derived: 9-month figure less the 6-month figure.Report this figure(8.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure(18.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$18.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(6.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001213900-26-086151. Derived: 6-month figure less the 3-month figure.Report this figure(6.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-109983. Derived: 9-month figure less the 6-month figure.Report this figure(14.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001213900-26-031862. Derived: 12-month figure less the 9-month figure.Report this figure(15.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure(9.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001213900-26-086151. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported3.4Share repurchases, Q1 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure6.5Share repurchases, Q2 FY2026, three months to 2026-06-30$6.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001213900-26-086151. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)112.38m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares30.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3030,063,735 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001213900-23-084737.Report this figure30.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3130,099,203 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001213900-24-040856.Report this figure30.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3030,099,203 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001213900-24-066111.Report this figure30.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3030,099,203 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001213900-24-095398.Report this figure30.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3130,132,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001213900-25-042025.Report this figure30.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3030,174,202 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001213900-25-073073.Report this figure30.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3030,174,202 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure30.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3130,408,890 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure33.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3033,191,622 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure33.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3033,191,622 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001213900-25-109983.Report this figure86.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3186,596,873 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001213900-26-055059.Report this figure112Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30112,375,941 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure

Shares outstanding: 106.67mShares outstanding, period not labelled, at 2026-08-04106,669,846 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001213900-26-086151.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.